Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Longboard Pharmaceuticals, Inc. | Director | Stock Option (Right to Buy) | 22.5K | May 23, 2024 | Direct | ||
ARENA PHARMACEUTICALS INC | Executive VP and CBO | Common Stock | 0 | $98.51 | Mar 11, 2022 | Direct | |
ARENA PHARMACEUTICALS INC | Executive VP and CBO | Employee Performance Restricted Stock Unit | 0 | Mar 11, 2022 | Direct | ||
ARENA PHARMACEUTICALS INC | Executive VP and CBO | Employee Stock Option (right to buy) | 0 | Mar 11, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
LBPH | Longboard Pharmaceuticals, Inc. | May 23, 2024 | 1 | $0 | 4 | May 24, 2024 | Director |
LBPH | Longboard Pharmaceuticals, Inc. | May 25, 2023 | 1 | $0 | 4 | May 26, 2023 | Director |
LBPH | Longboard Pharmaceuticals, Inc. | May 24, 2022 | 1 | $0 | 4 | May 31, 2022 | Director |
ARNA | ARENA PHARMACEUTICALS INC | Mar 11, 2022 | 10 | $0 | 4 | Mar 11, 2022 | Executive VP and CBO |
ARNA | ARENA PHARMACEUTICALS INC | Jan 3, 2022 | 1 | $0 | 4 | Jan 5, 2022 | Executive VP and CBO |
LBPH | Longboard Pharmaceuticals, Inc. | Sep 14, 2021 | 2 | $0 | 4 | Sep 14, 2021 | Director |